Research & Education

ELCC 2014: Lung adenocarcinoma with RET fusion: early experience with diagnosis and targeted therapy

March 31, 2014

Drs. Oliver Gautschi and Lukas Bubendorf discourse on the presence of RET aberrations in NSCLC; explain current diagnostic techniques and future screening possibilities; and call for more trials to validate use of promising targeted drugs, sending patients to active centres for broad testing.


The European Lung Cancer Conference (ELCC) is organised by the European Society for Medical Oncology (ESMO) and the International Association for the Study of Lung Cancer (IASLC). Attendees benefit from educational and scientific updates provided by thoracic oncology specialists on different multidisciplinary topics important for research and clinical practice in the field of lung cancer.